Navigation Links
Pharmacyclics Announces Subscription Price for Rights Offering
Date:7/15/2009

expiration date, at 5:00 pm Eastern Daylight Time, unless extended by the Company.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state. The rights offering will be made only by means of a prospectus. When available, copies of the prospectus may be obtained from the Company's Information Agent, Georgeson Inc., 199 Water Street, New York, New York 10038 by telephone at (212) 806-6859 (call collect) or 800-279-5722 (toll-free) or by email at pharmacyclics@georgeson.com. If you have any questions related to this rights offering please contact the Information Agent under the same number or call the company directly, Ramses Erdtmann VP of Finance, at 408-215-3325.

About Pharmacyclics

Pharmacyclics(R) is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of immune mediated disease and cancer. The purpose of the Company is to create a profitable business by generating income from products it develops, licenses and commercializes, either with one or several potential partners or alone as may best forward the economic interest of its stakeholders. Pharmacyclics strives to generate collaborations that allow it to retain valuable territorial rights and simultaneously fast forward the clinical development and commercialization of its products. Presently, Pharmacyclics has four product candidates in clinical development and two product candidates in pre-clinical development. The Company is headquartered in Sunnyvale, California and i
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference
2. Pharmacyclics Files Registration Statement for Rights Offering
3. Pharmacyclics Reports Second Quarter Fiscal 2009 Financial Results
4. Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth
5. Pharmacyclics Secures $5.0 Million in Debt Financing
6. Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
7. Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results
8. Pharmacyclics Announces It Received Nasdaq Notice of Compliance
9. Pharmacyclics Announces It Received Nasdaq Notification
10. Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
11. Blue Marble Energy Corp. Announces Successful Close of Series A Financing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...to be able to charge their cell phones and other p...ecent discovery made by UC San Diego engineers cou...hat could do just this. , In recent research, p...andaru, a professor in the UCSD Department of Mech...ate student Mark Hoefer, have found that artificia...
(Date:11/19/2009)...ESDA, Md., Nov. 19 Spher...biotechnology for diabetes therapy, and a provider...o food, supplement, biotechnology and pharmaceutic...usly reported $6.3 million registered direct place...s of its common stock and warrants to purchase up ...
(Date:11/19/2009)...Germany, November 19 MONITORING FO...r 16th, 2009 Flibanserin in the,indication treatme...on,s,disease for orphan drug status designation wi...induced dyskinesia is a complication of the mainst... burden to some of those,affected, since it may be...
(Date:11/19/2009)...nSound is honored by latest award for revolutionar...CA (PRWEB) November 16, 2009 -- Popular Science Ma... hearing aid from InSound Medical a winner of its ...th category.    Chosen from th...eep in the hearing canal for up to four months whi...
Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
...robiotics, the friendly bacteria beloved of yoghur...growth promoting antibiotics in pigs, giving us sa...g today (Wednesday 5 September 2007) at the Societ...niversity of Edinburgh, UK, which runs from 3-6 Se...y Laboratories Agency in Weybridge, Surrey have sh...
...Imagine using minuscule structures the size of mol...ctricity. Or employing the same structures to stor...nk. Or replacing todays semiconductors with these ...ll, powerful electronics. , These technologies do...University of Wisconsin-Milwaukee (UWM) is bringin...
...REENBELT, Md. - A NASA-developed innovative proces...spurring the development of new companies in the p...tailor, has licensed NASA Goddard Space Flight Cen... fabrication process with plans to make high-quali...tential markets for the technology are vast and in...
Other Biology Technology:Probiotic good bugs may control gut infections 2Two nanostructures are better than one 2Two nanostructures are better than one 3Two nanostructures are better than one 4NASA technology forms the basis for a new nanotechnology company 2
(Date:11/20/2009)...ehigh University,s Energy Research Center (ERC) ha... Energy (DOE) to develop methods of recovering and...arbon-dioxide (CO 2 ) compression process in a car...ct is to facilitate carbon capture and sequestrati... CO 2 , a greenhouse gas, emitted into the atmosph...
(Date:11/19/2009)...t,s a naturally occurring brain chemical with an u...outh, it can be abused or used as a date-rape drug... have determined new routes by which 4-HB is metab...ormation," said K. Michael Gibson, professor and c...cal University and a member of the research team. ...
(Date:11/19/2009)...ADISON Leaf-cutter ants, which cultivate fungus f...,s a new one to add to the list: the ant farmers, ...fixing bacteria to make their gardens grow. The fi... Science , documents a previously unknown symbios...into how leaf-cutter ants have come to dominate th...
Breaking Biology News(10 mins):Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Researchers begin to decipher metabolism of sexual assault drug 2Like humans, ants use bacteria to make their gardens grow 2Scientists open doors to diagnosis of emphysema 9456 1Scientists open doors to diagnosis of emphysema 9456 2Webcast Alert 3A Medial Saude S A Announces Second Quarter 2009 Earnings Conference Call Webcast 53485 1SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 1SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 2SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 3SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 5
...orders in humans are genetically based. The influ...clear. Given that studies of humans are complicat...g factors, researchers in the March issue of Alco...rhesus monkeys to examine genetic and environmenta...cate that, just as with humans, both genetic and e...
...any types of protected areas will be needed to pro...out the comparative performance of inhabited and u...rm of forest disturbance: conversion to agricultur...n Biology (2006, Vol 20, pages 65-73), an internat... the Woods Hole Research Center and the Instituto ...
...chers by showing an unexpectedly successful approa...eir innovative strategy is gluttony. , The disco...awaii , provides new insights into how these tiny ... The report by Ohio State University researchers i...urnal Nature. , During the past decade, reports ...
Other Biology News:Genetic and environmental influences on alcohol consumption among rhesus monkeys 2Satellites show Amazon parks, indigenous reserves stop forest clearing 2Satellites show Amazon parks, indigenous reserves stop forest clearing 3Tiny polyps gorge themselves to survive coral bleaching 2Tiny polyps gorge themselves to survive coral bleaching 3
...tly, no readily available affinity chromatography ...andard methods for IgM purification generally are ...ective for removing all of the major impurities pr... easy-to-use affinity matrix and buffer system to ...
...mamido)-3′-deoxy-N,N-dimethyladenosine, 2HCl.... Protein synthesis inhibitor. Inhibits translatio...ide chains. Induces DNA fragmentation in thymocyte...98% by TLC. Soluble in H 2 O. RTECS AU7355000, CA...
...s solution that contains a purified bovine protein...osphate buffered saline), pH 7.0 7.4. This produ...munoassay Stabilizer preserves the conformation an...says and can be used as a coating or lyophilizatio...
Mouse Anti-Human BTG2 Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: